← Back
$CRSP All transactions

CRISPR Therapeutics AG

M

$ Value

Shares

25,000

Price

Filed

Aug 19

Insider

Name

Kulkarni Samarth

Title

Chief Executive Officer

CIK

0001682019

Roles

Director Officer

Transaction Details

Transaction Date

2025-08-16

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. | Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. | This restricted stock unit award was granted on August 16, 2022 with respect to 25,000 Common Shares, with 100% of the shares vesting on August 16, 2025.

Filing Info

Accession No.

0001682019-25-000003

Form Type

4

Issuer CIK

0001674416

Kulkarni Samarth's History

Date Ticker Type Value
2026-03-23 CRSP $469K
2026-03-20 CRSP M
2026-03-20 CRSP A $0
2026-03-20 CRSP A $0
2026-03-20 CRSP M
2025-10-17 CRSP $3.5M
2025-10-16 CRSP M
2025-10-16 CRSP M
2025-10-14 CRSP $283K
2025-10-13 CRSP M

Other Insiders at CRSP (90d)

Insider Bought Sold Last
Kulkarni Samarth
Chief Executive Officer
$469K 2026-03-23
KASINGER JAMES R.
General Counsel and Secretary
$149K 2026-03-23
Prasad Raju
Chief Financial Officer
$173K 2026-03-23
Patel Naimish
Chief Medical Officer
2026-03-20